Vycor Medical Ratios (2010-2023) | VYCO

Ratios Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Profitability
Gross Margin (Quarter) 91.73%83.18%83.06%84.58%75.27%84.31%81.80%81.64%84.83%88.47%87.99%87.04%88.13%87.00%89.35%91.50%86.39%91.47%91.76%89.52%
EBT Margin (Quarter) -561.62%-501.36%-814.81%-644.77%-1,289.43%-496.85%-189.66%-181.10%-300.59%-356.69%-210.63%-286.04%-273.43%-161.14%-23.51%-29.80%-36.23%2.10%14.66%-16.68%
EBIT Margin (Quarter) -545.85%-488.22%-803.40%-628.28%-1,268.67%-480.12%-176.69%-175.67%-279.86%-346.35%-184.24%-258.82%-259.46%-150.55%-16.86%-22.68%-28.40%9.20%19.99%-8.26%
EBITDA Margin (Quarter) -545.85%-488.22%-803.40%-655.22%-1,297.37%-392.98%-167.93%-162.41%-255.02%-317.87%-162.94%-231.65%-232.41%-157.61%-23.75%-30.19%-37.04%1.90%14.17%-16.82%
Operating Margin (Quarter) -545.85%-488.22%-803.40%-628.28%-1,268.67%-480.12%-176.69%-175.67%-279.86%-346.35%-184.24%-258.82%-259.46%-150.55%-16.86%-22.68%-28.40%9.20%19.99%-8.26%
Net Margin (Quarter) -561.62%-501.36%-814.97%-644.77%-1,289.43%-496.85%-189.66%-181.10%-300.59%-356.69%-210.63%-286.04%-273.43%-161.14%-75.43%-30.19%-89.36%-43.03%14.17%-69.38%
FCF Margin (Quarter) -467.39%-346.18%-388.33%-591.37%-456.91%-175.71%-90.91%-127.28%-156.74%-112.49%-118.19%-25.10%-6.49%-24.73%6.82%2.93%-4.82%
Efficiency
Inventory Average (Quarter) 0.09M0.15M0.25M0.32M0.33M0.31M0.28M0.26M0.26M0.23M0.20M0.23M0.26M0.24M0.23M0.21M
Assets Average (Quarter) 4.58M3.99M3.49M3.07M2.71M2.63M2.44M2.26M2.23M1.60M0.92M0.93M0.90M0.85M0.87M0.98M
Equity Average (Quarter) 1.84M1.31M0.63M-0.03M-0.81M-1.32M-1.77M-2.24M-2.62M-2.70M-2.59M-2.71M-2.88M-3.02M-3.06M-3.13M
Invested Capital (Quarter) 0.09M1.94M1.74M0.88M0.38M-0.45M-1.17M-1.46M-2.08M-2.41M-2.82M-2.59M-2.60M-2.82M-2.94M-3.10M-3.02M-3.23M
Asset Utilization Ratio (Quarter) 0.140.240.360.450.510.460.410.430.480.691.301.371.051.181.331.18
Leverage & Solvency
Interest Coverage Ratio (Quarter) -34.62-37.15-70.34-38.12-45.58-34.40-25.53-24.05-56.27-33.49-6.98-20.70-18.58-14.21-4.30-7.44-8.512.697.23-2.05
Debt to Equity (Quarter) 0.68-0.06-0.06-0.05-0.05-0.05-0.05-0.04
Debt Ratio (Quarter) 0.280.160.160.150.170.170.160.14
Equity Ratio (Quarter) 0.040.410.400.250.11-0.16-0.44-0.57-0.89-1.09-1.25-2.77-2.86-2.97-3.42-3.71-3.33-3.07
Times Interest Earned (Quarter) -34.62-37.15-70.34-38.12-45.58-34.40-25.53-24.05-56.27-33.49-6.98-20.70-18.58-14.21-4.30-7.44-8.512.697.23-2.05
Valuation
Enterprise Value (Quarter) -0.13M-0.04M-0.13M-0.19M-2.21M-1.83M-0.95M-0.41M-0.17M-0.26M-0.06M-0.02M-0.02M-944.00-0.08M-0.04M-0.03M-0.04M-0.05M-0.05M-0.07M
Return Ratios
Return on Sales (Quarter) -5.62%-5.01%-8.15%-6.45%-12.89%-4.97%-1.90%-1.81%-3.01%-3.57%-2.11%-2.86%-2.73%-1.61%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%
Return on Capital Employed (Quarter) -2.44%-3.59%-9.68%33.56%2.65%2.01%1.35%1.07%0.78%1.00%0.50%0.26%0.06%0.01%-0.01%
Return on Assets (Quarter) -1.04%-1.20%-1.32%-1.17%-1.19%-1.13%-1.17%-1.19%-1.09%-1.14%-1.26%-0.56%0.00%0.00%0.00%0.00%
Return on Equity (Quarter) -2.60%-3.65%-7.35%114.96%3.98%2.26%1.61%1.20%0.93%0.67%0.45%0.19%0.00%0.00%0.00%0.00%